Cite
HARVARD Citation
Mitsuoka, S. et al. (2016). Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lung cancer with wild-type EGFR. Expert opinion on pharmacotherapy. pp. 193-203. [Online].